SCHEMBL30657255

SCHEMBL30657255

CCOC(=O)C[C@@H](C)Cc1ccc(Oc2cccc(Br)c2C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.35
PPARA Q07869 4/20 0.35
EPHX2 P34913 1/20 0.35
ADRB2 P07550 2/20 0.35
ADRB1 P08588 2/20 0.35
ADRB3 P13945 2/20 0.35
CARM1 Q86X55 3/20 0.34
PRMT6 Q96LA8 3/20 0.34
MME P08473 1/20 0.34
ACE P12821 1/20 0.34
CPA1 P15085 1/20 0.34
ACE2 Q9BYF1 1/20 0.34
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
PPARD Q03181 2/20 0.34
MMP8 P22894 1/20 0.33
ADAM17 P78536 1/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26639764 1.00 PPARG (0.35) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL30657349 1.00 PPARG (0.35) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL30657439 1.00 PPARG (0.35) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL26639809 0.87 ITGB3 (0.43) PPARGPPARAPPARD
SCHEMBL26639817 0.87 ITGB3 (0.43) PPARGPPARAPPARD
SCHEMBL26639808 0.87 ITGB3 (0.43) PPARGPPARAPPARD
SCHEMBL30657419 0.86 FFAR1 (0.36) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL30657375 0.86 FFAR1 (0.36) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL30657362 0.86 FFAR1 (0.36) PPARGPPARAEPHX2ADRB2ADRB1
SCHEMBL26639558 0.86 FFAR1 (0.36) PPARGPPARAEPHX2ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288683-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2025-09-18 US disclosed
EP-4519272-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2025-03-12 EP disclosed
WO-2023215449-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2023-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250288683-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS BCL2L1, BCL2, BCL2L10 PPARG 3153/4885PPARA 4355/4885EPHX2 2725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.